The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Guidance for Industry Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products


U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research

Document Type:
Guidance for Industry
Recommendations related to Donor deferral to minimise transmission risk of HIV via blood and blodd components

Go back

GMP Conferences by Topics